Introduction
Treatment of vitreoretinal diseases has been revolutionized by the introduction of pars plana vitrectomy (PPV) by Machemer et al. (1971) , and the success has led to further development of techniques and instruments (Kim et al. 2015b) . Epiretinal membrane (ERM) is one retinal disease where a recognized and well-established treatment includes vitrectomy (Kofod et al. 2016) . Although the procedure is associated with a low incidence of complications, cataract progression requiring cataract surgery remains a common complication (Shousha & Yoo 2010) . Presbyopic phakic eyes with ERM thus need both surgeries (vitrectomy and cataract surgery) either simultaneously or sequentially. They may be offered (1) combined simultaneous phacovitrectomy, (2) initially vitrectomy and then wait for the cataract to develop, or (3) clear lens extraction (because cataract is expected to progress) followed by vitrectomy (Savastano et al. 2014) . Cataract surgery is the most common ocular surgical procedure performed and consists of removal of the lens fibres and replacing it with an artificial intraocular lens (IOL). It is not solely a treatment for cataract but is also regarded as a refractive procedure. The prediction error of the refractive outcome is termed the refractive error (RE), and the RE may cause an unintended anisometropia impairing binocular visual function. Several studies have described a small myopic RE after vitrectomy independent of whether it is performed in combined or sequential surgery . Cystoid macular oedema (CME) is a complication to intraocular surgery, and the presence of ERM is a risk factor for CME development (Henderson et al. 2007 ). Combined surgery may result in higher incidence of CME due to possibly more inflammation and longer duration of surgery. Surgery may also cause a loss of corneal endothelial cells (ECs), and the loss can be considered an indication of the magnitude of the surgical trauma (Bourne et al. 2004) . The ECs play an important role in maintaining corneal transparency and thus the optical function of the cornea. The concerns of corneal complications are rarely the emphasis in vitreoretinal surgery, nonetheless corneal decompensation is not a negligible cause of visual loss after an otherwise successful surgery (Pang et al. 1986) . Additional attention to the EC must therefore be paid in eyes with concomitant vitreoretinal diseases, particularly in cases where good postoperative visual outcome is expected, like ERM. The patients' expectation to surgical outcome is increasing, including the expectancy to achieve a desired refraction. It is therefore interesting to investigate whether the sequence of surgery and the phakic status plays a role in presbyopic eyes with ERM. Furthermore, combined surgery may be more satisfying than sequential surgery because the patients are treated in a single step and have not to return when the cataract develops.
Objectives and Hypotheses

Objectives
• Develop a clinical guideline regarding the sequence of surgery for phakic presbyopic eyes with ERM.
• Study the impact of the sequence of surgery (either sequential or combined) on the RE, the incidence of CME and the EC loss. • The RE is similar in combined and sequential surgery.(Paper II)
• The incidence of CME (Paper II) and the loss of EC (Paper III) are highest in combined surgery because of a bigger surgical trauma in a single step.
Background General
Epiretinal membrane is a disorder of the vitreomacular interface consisting of a thin sheet of fibrocellular membrane that lays immediately on the inner surface of the retina on the internal limiting membrane (Stevenson et al. 2016) . It is also known as macular pucker and cellophane maculopathy and is a frequent retinal condition mostly occurring in individuals older than 50 years with a prevalence of 5% (Ng et al. 2011) . The major risk factor for developing ERM is age, but several others have been identified: previous intraocular surgery (cataract surgery is one of the most important), race, sex, smoking, diabetes, hypercholesterolaemia, uveitis, laser photocoagulation, retinal vein occlusion and retinal detachment (Aung et al. 2013) . It is classified as idiopathic when found in otherwise healthy eyes and secondary if the aetiology is associated with other ocular diseases. Posterior vitreous detachment is the separation of the vitreous from its posterior attachments and is present in 95% of cases with idiopathic ERM (Wiznia 1986) . Although the pathogenesis of ERM is still debated, the association with posterior vitreous detachment has been explained by several theories. The classical theory describes breaks in the internal limiting membrane because of the posterior vitreous detachment allowing glial cells to migrate to the surface of the retina to form a membrane (Foos 1977 ). An alternative theory involves an anomalous posterior vitreous detachment where liquefaction of the vitreous exceeds vitreoretinal adhesion weakening resulting in vitreoschisis and vitreoretinal traction (Kampik 2012) . Remnants of the vitreous are left in the macula, and the traction induces production of cytokines that stimulate residual vitreous cells to proliferate (Joshi et al. 2013) . Fibroblasts contribute by producing collagen, and myofibroblasts secrete proteins and induce intracellular contraction that possibly accounts for the contractile properties of late ERM. ERM thus consists of two main components: extracellular matrix and cells (Kampik 2012) .
Epiretinal membrane is in general a chronic disease usually with slow onset and progression, but the natural history is very variable; some cases are nonprogressive, only mildly affecting vision, while others experience worsening of visual complaints. In early stages it typically does not cause visual impairment and can be an incidental finding (Bu et al. 2014) . As the membrane thickens and contracts the appearance becomes more grey and opaque, and retinal folds, tractional lines, vascular tortuosity or dilatation may be seen. It then becomes a bothering condition causing distorted and decreased vision. Decreased vision can be assessed by measuring the visual acuity (VA), which conventionally is measured as the best-corrected visual acuity (BCVA). It is a commonly reported parameter to quantify functional impact of macular diseases (Larsson et al. 2005) , although it is also affected by other ocular morbidities, and it evaluates the whole visual pathway. Different tests of the BCVA have been developed including The Early Treatment Diabetic Retinopathy Study (ETDRS) chart. The BCVA measured with the ETDRS chart is related to the retinal architecture and is a good indicator of retinal function (Sim et al. 2013) . It is a reliable test and is by some considered to be the gold standard in BCVA testing (Kaiser 2009) . A simple test to detect metamorphopsia is the Amsler chart consisting of parallel lines with a central fixation spot.
Diagnosis was previously based on clinical examination by fundoscopy and fundus photograph. With advances in retinal imaging, the optical coherence tomography (OCT) is increasingly used to diagnose and monitor retinal diseases affecting the macula with much higher accuracy (Browning et al. 2004) . OCT is a noncontact technique capable of producing high-resolution cross-sectional images in vivo to evaluate retinal morphology and thickness. It is routinely used in ERM, and retinal specialists rely on OCT as well as patient's symptoms in making surgical decisions (Do et al. 2006) . Spectral domain OCT has a high-axial resolution, great reproducibility and reduced motion artefacts, and its superiority has been demonstrated in ERM (Falkner-Radler et al. 2010 ). On OCT, the ERM appears as a hyperreflective layer on the top of the internal limiting membrane (Fig. 1) .
The central macular thickness is the distance between the inner retina and the retinal pigment epithelium. Macular thickness is reported as either centre point thickness or mean central subfield macular thickness (CSMT). The last is preferred as it is the average of more data points, is less dependent on scan centration and has a higher reproducibility (Browning et al. 2008) . In ERM, the retinal thickening extends often across the whole macular area, but the CSMT measures only the central part of the macula, while the macular volume (MV) assesses a wider area and represents retinal thickness in the entire macula (Aso et al. 2009 ). CSMT and MV are findings on OCT, and thickness evaluation is an effective tool to characterize the ERM and objectivize morphological surgery outcome (Falkner-Radler et al. 2010) .
Surgery
Treatment includes a vitreoretinal surgical procedure consisting of removal of the vitreous by PPV and removal of the ERM by peeling. Surgery has proven its efficiency and has been tested in numerous studies (Kofod et al. 2016) . The cost-effectiveness is favourable with improvement of visual function and quality of life (GhaziNouri et al. 2006) . The VA improves more than two Snellen lines following surgery in 70-90%, and metamorphopsia is reduced in 60-80% of the patients. Improvement occurs mainly during the first year after surgery, but it can take years before the full recovery of VA, and metamorphopsia has been reached (Bouwens et al. 2008) . The recurrence rate is 5-10%, but only 2% require a second surgical intervention, and the internal limiting membrane peeling reduces the risk of recurrence (Sandali et al. 2013) . Despite the widespread performance of surgery, there are no established guidelines for case selection. An acceptable policy that balances between the benefits and risks is to recommend surgery based on patients' subjective symptoms and the VA (Moisseiev et al. 2016) . With improvement in surgical technique and its availability, the threshold for surgery has decreased and is currently even offered to eyes with good VA (Reilly et al. 2015) . Although individualized, VA and binocular complaints are commonly used as indicators for timing of surgical intervention. The asymptomatic and nonprogressive cases are not candidates for surgery and can be observed, having in mind that progression rate is 16-33% (Fraser-Bell et al. 2003) .
Vitrectomy has previously been performed with 20-gauge instruments, but small-gauge instrumentation (23-, 25 and 27-gauge) is now available offering several advantages over 20-gauge: smaller sutureless incision, faster visual recovery, less surgically induced astigmatism and improved patient comfort (Kim et al. 2015) . Complications to vitrectomy include retinal tears and detachment (incidence 1-2%), vitreous haemorrhage (1%) and endophthalmitis (0.05%; Pielen et al. 2014) . Despite continuous advances in technique and safety, cataract progression is the most common complication even with smallgauge instrumentation (Almony et al. 2012) . The pathogenesis for cataract development remains unclear, although some factors have been identified: advanced patient age, light toxicity from the operating microscope, intraoperative oxidation of lens proteins, intravitreal tamponade, mechanical trauma and exposure to irrigation solution (Shousha & Yoo 2010) . Cataract progression requiring cataract surgery occurs within 2 years after vitrectomy in the vast majority of patients aged above 50 years (de Bustros et al. 1988) . Cataract is a condition characterized by clouding of the lens causing visual impairment. The function of the lens is to focus the image on the retina by accommodation, that is changing the curvature of its surface. With age, the accommodative power of the lens is reduced causing presbyopia (Vrensen 2009 ). Phacoemulsification is the preferred surgical technique where the lens fibres are emulsified with ultrasound and aspirated, and an artificial IOL implant is usually placed in the lens bag.
Refractive outcome
The refractive status of the eye after cataract surgery depends on the power of the IOL. The expectations to achieve a desired target refraction (particularly emmetropia) have heightened to a level of great demand and is now a major aim of cataract surgery (Jivrajka et al. 2012) . Because of the good VA outcome of vitrectomy for ERM, it is even more important that subsequent cataract surgery accurately matches the desired refraction. The method of calculating the postoperative refraction commonly consists of a formula that takes account of the eye's biometry. The RE is about 0.50 D and is reported to be mainly towards myopia when vitrectomy is added to cataract surgery . The observed RE is the sum of errors of many parameters, including the inaccuracy of the formulas that calculate the expected IOL position and the measurement error of the biometric measurements ). Preoperative biometry assessment is a major factor in obtaining favourable refractive outcome, and the enhanced refractive predictability is in part due to more precise biometric measurements of axial length (AL), anterior chamber depth (ACD) and keratometry (K; Aristodemou et al. 2011b ).
Axial length
Accurately measured AL is essential for prediction of the postoperative refraction. A 0.1 mm error in AL is equivalent to an error of 0.27 D in the spectacle plane; so accuracy within 0.1 mm is necessary. The errors in the RE are in 54% of the cases attributed to AL measurement errors, 38% in errors in estimation of postoperative effective lens position and 8% to corneal power errors (Olsen 1992) . AL measurements can be obtained either by A-scan ultrasound or partial coherence interferometry using either the internal limiting membrane (for ultrasound) or the retinal pigment epithelium (for partial coherence interferometry) as end-points (Kovacs et al. 2007 ). The globe indentation by the ultrasound probe and a thickened macula as in ERM makes the ultrasound-AL shorter. In contrary, the noncontact infrared diode laser in the partial coherence interferometry technique (available in the IOLMaster (Carl Zeiss, Dublin, CA, USA)) is not influenced by macular oedema and measures in the visual axis resulting in higher accuracy and improved refractive predictability (Findl et al. 2001) . Furthermore, the focal plane of the eye corresponds to the external limiting membrane (Williams et al. 1994) , which is closest to the end-point of the partial coherence interferometry (Fig. 2) .
Anterior chamber depth
The human eye can be considered a dual lens system; the cornea and the retina have fixed positions, and the effective power of the system depends on power and position of the IOL. Empirical estimation of the postoperative IOL position is based on the statistical association between various preoperative measurements and the postoperative ACD (Olsen 2007a ). The ACD is considered a pseudomeasurement of the effective lens position as if the lens was of infinite thickness. Several IOL power formulas require ACD measurements, and accurate measurements are essential to minimize unwanted RE. The IOLMaster uses a photographic technique to automatically measure the ACD by slit illumination. It is reliable in phakic eyes, but its reliability is controversial in pseudophakic eyes (Nemeth et al. 2003) . The Pentacam (Oculus, Wetzlar, Germany) uses a Scheimpflug camera and provides slit images to create a 3-dimensional image where the ACD is calculated. Both are noncontact devices with automated acquisition and data analysis with high repeatability and reliability (Utine et al. 2009 ). Cataract surgery deepens the anterior chamber because a thick natural lens is replaced by a thin IOL (Kucumen et al. 2008) . The IOL moves forward towards the cornea during the first month followed by a slight backward movement until 6 months after surgery. Axial movements of the IOL reflect the interaction between capsular fusion, the fibrotic reaction and the mechanical resilience of the IOL in withstanding the contracting forces (Petternel et al. 2004) . A 1 mm forward movement of the IOL produces myopia of 1.5 D or even more in hyperopic eyes.
Keratometry
Corneal power accounts for the majority of the dioptric power of the eye. A 0.1-mm error in K-readings corresponds to a RE of 0.57 D, so high accuracy is needed. The IOLMaster has an incorporated auto-keratometer that measures the anterior corneal curvature and power by assuming a fixed correlation between the curvature of the anterior and the posterior surfaces (Karunaratne 2013) . In contrary, the Pentacam measures the curvature and radius on both surfaces of the cornea and calculates the total corneal power using the correct refractive index (for cornea, aqueous humour and air). This K-value is not suitable for IOL power calculation formulas; however, the Pentacam is able to calculate an equivalent K reading that can be used in IOL power formulas by evaluating the anterior corneal surface and adjust it to reflect the posterior surface. Nevertheless, the equivalent K value results in a bigger RE compared to the K value obtained from the IOLMaster, probably due to measurements in different diameters of the cornea (2.3 mm in the IOLMaster and 1-7 mm in the Pentacam; Shammas et al. 2009; Karunaratne 2013) . Regarding the surgical setting, the small sutureless incisions have reduced the surgical component of the RE including the surgically induced astigmatism, giving the spherical component more attention (Naeser & Hjortdal 2011) .
The vitreous
The vitreous gel is replaced by aqueous after vitrectomy. For simplicity, the optical properties including the refractive index are assumed to be identical in IOL power calculations. However, they differ slightly, and the refractive index of the vitreous gel is higher (Sardar et al. 2007 ). If adjustment is made in theoretical calculations in a schematic eye, this small difference can explain a myopic shift of 0.13-0.50 D (Shioya et al. 1997; Mehdizadeh & Nowroozzadeh 2009 ). Intravitreal gas tamponade may be used in ERM surgery in cases with peripheral retinal tears or to ensure leakage from sutureless sclerotomy. The gas bubble possesses high surface tension and applies buoyant force on the anterior chamber, thereby creating enough force to shallow the chamber by pushing the IOL forward causing a myopic shift. The duration of the different gas types differs, but with time the gas dissipates from the vitreous cavity and the anterior chamber deepens (Neudorfer et al. 2011) . Studies have reported a more myopic RE in phacovitrectomy if intravitreal gas is used .
Formula for power calculation
Formulas that predict the postoperative refraction are based on two principles, statistical-regression and theoretical-optical. The regression method is a statistical approach based on data obtained by working backwards on postoperative outcomes. This empirical method eliminates the need to make assumptions because it is based on actual measurements. The algorithms work only if the circumstances used in the regression model are unchanged, for example the biometry device and the surgical technique (Olsen 2007) . In contrary, the theoretical formulas are based on mathematical principles and geometrical optics of the schematic eye and contain many assumptions. More sophisticated thirdand fourth-generation formulas have been developed based on both theoretical and statistical principles; for example, the SRK-T is an optical formula that has been empirically optimized, thus combining the advantages of theoretical and regression formulas. The most striking difference between old and modern formulas is the manner in which the IOL position is calculated. No formulas have been developed for vitrectomized eyes or for phacovitrectomy with or without gas tamponade (Aristodemou et al. 2011) . However, the newer generation formulas should be more suitable because of their superiority and improved accuracy, and because the IOL position is more accurately taken into account (Manvikar et al. 2009 ).
Sequence of surgery
The majority of patients with ERM are elderly and thus presbyopic. Some of these might have simultaneous cataract. A standardized evidence-based approach of the sequence of surgery to offer (either combined or sequential) is necessary in phakic presbyopic eyes assigned for ERM surgery.
Combined surgery
During the combined phaco-vitrectomy procedure, the cataract surgery and the vitrectomy are performed during the same session. The approach is safe, and the functional and anatomical results are equivalent to consecutive surgery (Dugas et al. 2010) . It has gained popularity and is routinely performed in some clinics. The decision to pursue combined surgery depends on many factors, including surgeon skill, case characteristics and patient preferences. It has benefits such as improved intraoperative view of the retina, facilitates a more complete vitrectomy, rapid visual rehabilitation and is costeffective (Seider et al. 2014) . A major advantage is that the patient' spathology can be solved in a single step. Disadvantages are instability of the cataract wound during globe manipulation, loss of corneal transparency during surgery and theoretically more postoperative inflammation due to longer duration of surgery (Chung et al. 2002) . The surgically induced astigmatism in combined surgery is not different to that induced by either procedure alone (Yuen et al. 2009 ). Numerous studies have reported a myopic RE in combined surgery regardless of other influencing factors (biometry device, ocular pathology, instrumentation gauge and gas tamponade; .
Vitrectomy first
In cases where ERM is the main reason for the visual impairment, it is obvious to start performing the vitrectomy first and wait for the cataract to develop. However, the intraoperative view may not be optimal if cataract is present. While the cataract matures, the patient will go through a period of probably 1-2 years with progressive visual loss, additional costs to new spectacles and several eye examinations until the cataract surgery is performed. Elderly can thereby experience unnecessary hospitalization. At the time they return the cataract is dense, and surgery in vitrectomized eyes is technically more challenging and is associated with higher complication rates due to anatomical changes (Diaz et al. 1998 ). The RE of cataract surgery in vitrectomized eyes is also reported to be slightly myopic .
Cataract surgery first
Performing cataract surgery before the cataract has developed (or is only moderate) is technically more easy than in vitrectomized eyes and usually less ultrasound energy is necessary. The intraoperative view during subsequent vitrectomy is improved, but can, however, be impaired in case of posterior synechiae or a smaller pupil due to sequelae of the cataract surgery (Christensen et al. 2009 ). The edge of the implanted IOL can cause optical aberrations and reflexes interfering with the view. In addition to the RE of the cataract surgery itself, subsequent vitrectomy results in a myopic shift ). Performing cataract surgery in an eye that has not yet developed cataract is justified by the high incidence (up to 80%) of postvitrectomy cataract (Shousha & Yoo 2010) . In some cases, the cataract surgery may be sufficient to resolve the visual complaints of the patients. In research investigating the outcome of vitrectomy, some studies may perform cataract surgery in phakic eyes prior to vitrectomy to avoid the bias of progressive cataract on outcome (Kofod et al. 2016 ).
Corneal endothelium
The single layer of endothelial cells (EC) at the posterior surface of the cornea plays a crucial role in maintaining the corneal transparency and hence ensures a clear retinal image is formed. The EC functions as a barrier to fluid movement into the cornea and as a pump to move water and ions out of the stroma. The endothelium thus regulates the hydration state and prevents accumulation of fluid in the cornea which otherwise would interfere with the optical function (Bourne 2003) . The corneal endothelial cell density (CED) changes throughout life with an average annual cell loss rate in adults of 0.6% (Bourne et al. 1997) . If the CED drops below a threshold, the function is compromised resulting in decompensation, loss of transparency and oedema. The capacity of repair in response to trauma is limited, making damage to the EC potentially serious. Endothelial wound-healing consists of two mechanisms: enlargement and centripetal migration of EC. The defect left by lost cells is covered by surrounding cells that are enlarged and stretched in an attempt to take over the space of the degenerated EC (Kim et al. 2015) . In case of trauma to the EC, several EC parameters are affected in addition to the CED: the variation of EC shape and morphology, that is size and hexagonality (DelMonte & Kim 2011). There is a loss of EC during cataract surgery, and EC alterations are regarded as important parameters in evaluation of surgical trauma and estimation of surgical safety. The decrease in CED reflects the surgical trauma, whereas the change in morphology is associated with the repair process (Hugod et al. 2011) . Advances in surgical techniques and instrumentation have resulted in less invasive surgery with smaller EC damage; the CED is reduced by 5-15% after modern cataract surgery (Bourne et al. 2004; Storr-Paulsen et al. 2007 ) and by 1-4% after vitrectomy (Diddie & Schanzlin 1983; Friberg et al. 1984) . The timeframe for postoperative EC recovery ranges up to 6 months. In vivo EC assessment of structure and morphology is possible with specular microscopy, which is a noncontact imaging technology allowing a quantitative and qualitative evaluation (Szalai et al. 2011 ).
Macular oedema
Cystoid macular oedema is a complication to intraocular surgery resulting in a disappointing visual outcome, and CME may occur even after uneventful cataract surgery in otherwise normal eyes (Mentes et al. 2003) . The incidence in cataract surgery is <5%, but reported incidence ranges from 0 to 60% depending on the definition of CME (Grzybowski et al. 2016 ). The precise pathogenic mechanism is not fully understood, but it is multifactorial and attributed to inflammation. The CME is accompanied by disruption of the blood-retina and blood-aqueous barriers, increased vascular permeability and leakage. Surgical trauma to the iris, the ciliary body or the lens epithelial cells may induce the synthesis of inflammatory mediators facilitating this process (Miyake & Ibaraki 2002) . The incidence of CME peaks approximately 4-6 weeks postoperatively. The natural history of pseudophakic CME (i.e. CME after cataract surgery) is relatively benign; spontaneous resolution occurs in 70-80%, and duration is <6 months in 50% of the eyes (Benitah & Arroyo 2010) . As inflammation plays a key role in the development of pseudophakic CME, the management consists of anti-inflammatory medication including corticosteroids and nonsteroidal anti-inflammatory drugs. Preoperative prophylactic use of nonsteroidal anti-inflammatory drugs reduces the incidence of pseudophakic CME (Shelsta & Jampol 2011) . Eyes undergoing combined phaco-vitrectomy may have a higher incidence of CME due to theoretically more inflammation because of the bigger surgical trauma.
Methods Paper I
Purpose
To report the change in refraction in pseudophakic eyes following 23-gauge vitrectomy for idiopathic ERM, without use of silicone oil, intraocular gas or scleral buckling.
Study design
Retrospective study.
Settings
The study was carried out at the Department of Ophthalmology, Rigshospitalet Glostrup, Copenhagen, Denmark. The study was approved by the Danish Committee for Health Research Ethics (H42011129), and informed consent according to the tenets of the declaration of Helsinki was obtained from all subjects. Data handling and management were according to the guidelines described in the Danish Code of Conduct for
Research integrity (Ministry of Higher Education and Science 2014).
Outcome
The primary outcome was the RE. The absolute RE (the ARE) is the absolute value of the RE.
Participants
Participants were identified by review of charts in the period January 2008-December 2011.
Inclusion criteria:
• A diagnosis of idiopathic ERM;
• Previously uncomplicated cataract surgery with phacoemulsification and in-the-bag IOL implantation;
• Preoperative refraction less than AE5
D and astigmatism <3 D;
• Vitrectomy performed only because of ERM.
Exclusion criteria:
• Previous laser-refractive procedure;
• Intraocular surgery other than phacoemulsification and one vitrectomy for ERM had been performed at any time;
• The use of intraocular gas or silicone oil tamponade during vitrectomy;
• Intraoperative manipulation of the IOL;
• Serious complication (endophthalmitis, vitreous haemorrhage or retinal detachment).
Surgery
All surgeries were carried out by the same experienced surgeon (M.C.). Surgery consisted of a standard 23-gauge PPV with internal limiting membrane peeling and fluid-air exchange at the end of surgery. Laser photocoagulation was applied if any suspected or real retinal tears were found.
Examinations
Pre-and postoperative measurements were carried out by experienced staff members. Noncycloplegic refraction with a signal-to-noise ratio of 8 or better was made using a refractometer (Retinomax Ò , Nikon, Tokyo, Japan) and was used to guide subjective refractioning. Postoperative measurements were made more than 2 months after the vitrectomy.
Analysis
A computer database was created in MICROSOFT EXCEL as a fill-in form to record all patient data. All statistical analysis was performed using SAS software (release 9.1, SAS Institute Inc., Cary, NC, USA). Paired Student's ttest was used to compare the pre-and postoperative refractions in the vitrectomized eyes and in the fellow eyes. All refractions were expressed as spherical equivalents, and means were expressed using standard deviation. A p-value of 0.05 was used to declare statistically significant difference.
Paper II and III
Purpose
To assess the impact of combined phaco-vitrectomy and sequential surgery for idiopathic ERM on:
• Final RE and macular morphology (incidence of CME). (Paper II);
• EC loss and corneal biomechanical characteristics (i.e. central corneal thickness (CCT) and corneal volume (CV)). (Paper III).
Study design
Prospective interventional clinical trial.
Settings
The study spanned over the period January 2013 -March 2016 and was carried out at the Department of Ophthalmology, Rigshospitalet -Glostrup, Copenhagen, Denmark. The study was approved by the Danish Committee for Health Research Ethics (H22012020 and H15004292), and informed consent according to the tenets of the declaration of Helsinki was obtained from all subjects. Data handling and management were according to the guidelines described in the Danish Code of Conduct for Research integrity (Ministry of Higher Education and Science 2014). This study was registered at Clinicaltrial.-gov (NCT02413619).
Outcomes
Paper II:
• Primary outcome was the RE after 12 months.
• Secondary outcomes were BCVA and incidence of CME 12 months postoperatively. The CME was defined as a 10% increment or more of the CSMT as compared to the baseline disregarding the presence of cysts. This definition of the CME is similar to the definition of the PreMEd-study. (PREMEDgroup 2013) Paper III:
• Primary outcome was changed in CED after 12 months.
• Secondary outcomes were changes in CCT and CV after 12 months.
Participants
• Idiopathic ERM;
• Binocular visual complaints consistent with ERM;
• Age more than 50 years;
• Refraction less than AE5 D and astigmatism <3 D;
• BCVA more than 35 letters on the ETDRS chart.
• Previous intraocular surgery or laserrefractive procedure;
• History of previous head or ocular trauma;
• Retinal vein occlusion, wet macular degeneration, retinal detachment or uveitis;
• Any ocular or systemic morbidity significantly affecting VA, for example central corneal opacity, corneal dystrophy or advanced glaucoma;
• Poor co-operation;
• Inability to undergo surgery in local anaesthesia.
Allocation
Eligible patients were included and allocated into one of the three treatment arms:
• The CAT group: Cataract surgery first and subsequent vitrectomy after 4-6 weeks;
• The VIT group: Vitrectomy first and subsequent cataract surgery after 4-6 weeks;
• The COMBI group: Combined surgery (phaco-vitrectomy);
Allocation was guided by a randomization list; however, several participants refused the assigned allocation, and allocation based on patient's wishes was granted.
Power calculation
Paper II: A clinically important RE was defined as 0.50 D. To obtain a power of 80% and a type 1 error (significance level) of 5% with respect to the primary end-point (the RE), it was calculated that a sample size of 54 eyes was needed across the three arms (18 eyes per arm).
Paper III: A clinically important change in CED was defined as a loss of 300 cells/mm 2 . It was calculated that 18 eyes were needed in each group in order to obtain a power of 80% and a type 1 error (significance level) of 5% with respect to the primary outcome (the CED change).
Examinations
Clinical examinations were carried out by one experienced staff member (H.H.) and were performed at baseline, 2-4 weeks after the first surgery (the 'between visit'), and 1, 3 and 12 months after surgery. The examiner was not masked for the allocation sequence or intervention. Examinations were performed in identical physical environments and in the same order in each patient. Examinations included the following: 1 Noncycloplegic refraction with a signal-to-noise ratio of 8 or better was made using a refractometer (Retinomax Ò , Nikon) and was used to guide subjective refractioning. 2 Distance BCVA measured using the ETDRS protocol with the chart at an initial testing distance of 4 m. 3 Slit-lamp stereoscopic biomicroscopy, fundoscopy and Goldmann tonometry. 4 Ocular biometry was measured with the IOLMaster. The AL was calculated as an average of at least 10 measurements with an acceptable signal-tonoise ratio (more than 2.1). Multipeaked biometric measurements were repeated, and if persisted, the peak with the longest AL was approved. 5 CSMT and MV measured with spectral domain OCT (Heidelberg Engineering, Heidelberg, Germany). A fovea centred 30-degree scan with 25 lines was performed. Each aligned line represents the average of 25 scans. CSMT in the central millimetre and MV in the central 6 mm of the ETDRS grid were both assessed on OCT. All OCT scans, CSMT and MV measurements were reviewed to ensure correct layer identification (segmentation). 6 Measurement with a Scheimpflug tomographer in the Pentacam device with the 25-pictures scanning setting. The Pentacam provided the ACD, the CCT, the CV and keratometry values (K1 value at 90°, and K2 value at 180°). 7 Three photographs of each cornea were taken with a noncontact specular microscope (SP 3000P; Topcon, Tokyo, Japan). The pictures were analysed independently with the Image-net imaging system (version 3.16.0; Topcon). The Image-net software provided automated EC statistics, but an unblinded manual correction of the traced cell borders was performed, and the EC variables were recalculated as a mean of the three images. The CED, the variation in the size of the endothelial cells (the VAR) and the percentage of hexagonality were hereafter obtained.
Surgical procedures
All surgeries were in local anaesthesia. Cataract surgery was performed by experienced surgeons and included phacoemulsification with in-the-bag IOL implantation (AcrySof IQ SN60WF 1-piece IOL, Alcon or Tecnis ZCB00 1-piece IOL, AMO) through a 2.4 mm clear corneal or limbal incision. Vitreoretinal procedures were carried out by one experienced surgeon (M.C.) and included transconjunctival 23-gauge three-port PPV, internal limiting membrane peeling with the aid of ILM-blue (Brilliant Blue G, Dorc) and fluid-air exchange at the end of surgery. Laser photocoagulation was applied if any suspected or real retinal tears were found. The interval between the two surgeries was 4-6 weeks. In combined surgery cases, the cataract surgery was performed before PPV during the same session. Postoperative medication regimens consisted of topical nepafenac 1 mg/ml and a combination of dexamethasone/chloramphenicol, both administered four times daily for 3 weeks. After vitreoretinal procedures, dorzolamid/timolol was administered twice daily for 5 days. Patients with CME at follow-up visits received topical nepafenac four times daily until next follow-up.
Statistical analysis
A computer database was created in MICROSOFT EXCEL as a fill-in form, and all statistical analyses were conducted using SAS software (release 9.4, SAS Institute Inc.). Statistical assistance was provided by Section of Biostatistics, University of Copenhagen. One-way analysis of variance compared the three groups, while a paired t-test compared baseline to 12 months outcome in a single group. A p-value of 0.05 was used to declare statistically significant difference. Means were expressed using standard deviation. This trial was analysed with an intention-to-treat approach.
Last-observation-carriedforward was applied in case of missing or incomplete data at the 12-months follow-up. Patients that did not receive the intended treatment were excluded from the statistical analysis.
Results
Paper I
Twenty-eight eyes in 28 patients met the inclusion criteria in this retrospective study. There were no cases of surgical complications (retinal detachment, endophthalmitis or vitreous haemorrhage). The average age of the patients was 71.1 years (range: 57-84 years), 15 of them was women (54%), all Caucasian. The time between cataract surgery and vitrectomy was 12.1 AE 18.6 months (mean AE standard deviation, range: 1-72 months). The mean followup time (i.e. the time between the vitrectomy and the measured postoperative refraction) was 8.5 AE 6.5 months (range: 2-31 months).
The mean preoperative refraction was À0.15 AE 0.85 D, and the mean postoperative refraction was À0.41 AE 0.93 D. Hence, there was a significant myopic shift of À0.26 AE 0.60 D following vitrectomy (range: +0.75 to À2.13 D, 95% CI À0.48 to À0.03 D, p = 0.032). Fifty-four per cent of the eyes (15 eyes) had a refractive change towards myopia, 14% (4 eyes) had no change in refraction, and 32% (9 eyes) had a hyperopic change in refraction. The postoperative change in refraction was within AE0.25, AE0.50 and AE1.00 D in 39% (11 eyes), 68% (19 eyes) and 96% of the eyes (27 eyes), respectively, see significant (p = 0.87). The refraction of the fellow eyes did not change significantly (p = 0.82), neither among phakic (15 eyes, p = 0.42) or pseudophakic (13 eyes, p = 0.91) fellow eyes. One eye had posterior iris synechiae after vitrectomy, but had no change in refraction.
Paper II
Participant flow
Between January 2013 and December 2014, we assessed 137 patients with an idiopathic ERM and included 69 eyes (in 69 patients). Last follow-up examination (at 12 months) was carried out in January 2016. Seven eyes were excluded before allocation either because they withdrew their informed consent or did not meet the inclusion criteria after all (because of secondary ERM, advanced glaucoma or the need of general anaesthesia). Twenty-three eyes were allocated to the CAT group, 19 to the VIT group and 20 to the COMBI group. Flow is summarized in Fig. 4 . All participants were Caucasian. Four eyes in the CAT group did not receive the intended treatment according to allocation because of resolved visual complaints after cataract surgery, and subsequent PPV was no longer indicated. These four eyes were excluded from final statistical analysis of outcome.
Baseline data and complications
Baseline demographic and ocular characteristics are summarized in Lost to follow-up (n=0) Analysed (n=19) Figure 4 . Flow of participants from allocation to 12-month follow-up. Note that four patients in the CAT group did not have vitrectomy after the cataract surgery. The ACD was similar at baseline among the groups and increased after cataract surgery. Thus, the increase in the CAT group was just after the first step, and the VIT group had the increase after the second step. The ACD increase was not significantly different after 12 months in all groups (p = 0.13), see Table 2 . The AL decreased significantly after cataract surgery in all groups (p < 0.01). The AL did not change significantly (p > 0.05) between follow-up visits (1, 3 and 12 months).
Visual acuity outcome
All groups had an overall significant mean improvement of BCVA at follow-up, see Table 2 and Fig. 6 . The CAT group, however, had a slight decline in mean BCVA of six ETDRS letters at the 'between visit' which was 2-4 weeks after the cataract surgery. The small decrease in BCVA was consistent with a small increase in mean CSMT of 22 lm and higher incidence of CME, see Table 3 . The CAT group reached the baseline level 1 month after vitrectomy, and after 3 and 12 months all groups had a significant (p < 0.02) increase of BCVA with comparable final outcome (p > 0.05). The improvement in BCVA was greatest in the COMBI group, but without significant difference between the groups (p = 0.66 at 3 months, and p = 0.27 at 12 months). Interestingly, the BCVA kept improving between the 3-and 12-month visit for all groups, but only significantly for the CAT (p = 0.022) and the COMBI group (p = 0.026), not the VIT group (p = 0.26). Fifty-one eyes (84%) reached a BCVA of more than 69 letters on the EDTRS chart (corresponding to more than 20/40 Snellen fraction), and 44% gained three lines or more on the ETDRS chart (corresponding to halving of the visual angle). The proportion of three-line gaining eyes was not significantly different among the groups: 42%, 32% and 60% in the CAT, VIT and COMBI groups.
Macular outcome
The mean CSMT and MV decreased in all groups 1, 3 and 12 months after surgery, see Table 3 and Fig. 7 . The percentage decrement of CSMT after 3 months was 8.6, 10.5 and 8.1%; and after 12 months 14.1, 13.0 and 18.5% as compared to baseline. Thus, the CSMT continued to decrease after the 3-month follow-up; and the MV had a similar decrease. The decrement in CSMT and MV was greatest in the COMBI group, consistent with the greatest improvement in BCVA. After 12 months, the decrease in CSMT and MV was significant in all groups (p < 0.001), but the difference among the groups was not significant (CSMT: p = 0.26, MV: p = 0.19). The CME prevalence was 37% in the CAT group 2-4 weeks after the cataract surgery (the 'between visit'), but decreased to 5% (n = 1) at the last follow-up, see Table 3 . The VIT group also had one case (5%) after 12 months. The COMBI group had a CME prevalence of 10% (n = 2) after 1 month, 20% (n = 4) after 3 months, but all resolved after 12 months (n = 0).
Paper III
There were no cases of anterior capsular tear, dropped nucleus, posterior capsular rupture, use of iris hooks or malyugin ring, and none of the eyes had air in the anterior chamber following vitrectomy. No patient required any additional surgical intervention. Ocular characteristics at baseline were comparable in the three groups (p > 0.05), see Table 4 . The measured EC parameters (CED, VAR and hexagonality) at follow-up examinations are indicated in Table 5 , and the changes at the 12-month follow-up are calculated in Table 7 . In the groups with sequential surgery, the loss of EC can be differentiated between the two surgical procedures: The CED decreased just after the cataract surgery, but did not change significantly after the PPV. No eyes suffered of corneal decompensation, and no eyes had a CED of <1400 cells/mm 2 at 12 months. The coefficient of variance of EC size (the VAR) did not change significantly, see Tables 5 and  7 . The CCT increased in all groups, but only significantly in the COMBI group (10 lm, p = 0.005), see Tables 6 and 7 . The change in CV was also only significant in the COMBI group (p < 0.001). There was no change in the K1, but the K2 changed in all groups. No adjustments were needed for multiple comparisons because none of the outcomes were significantly different between the groups. With multivariate correlation analysis, we found that the CED at 12 months was strongly correlated with CED at baseline (r = 0.73). The change in CED was not correlated with the change in CCT (r = 0.15); however, the percentage CED loss was weakly correlated with the change in CCT but only in the COMBI group (r = 0.26).
Discussion Paper I
The refractive change in pseudophakic eyes following vitrectomy for various vitreoretinal pathologies has been found to vary between À0.15 and À0.84 D (Campo et al. 1999; Kumagai et al. 2001; Sharma et al. 2005; Byrne et al. 2008) . However, these studies also included eyes with intraocular gas tamponade. Our study reports the refractive changes following vitrectomy for ERM in 28 pseudophakic eyes without scleral buckling, silicone oil or gas tamponade. We found a refractive change of À0.26 D. Although this mean change is small, 43% (12 eyes) of the eyes had a clinically noticeable change of AE0.50 D or more. The RE in cataract surgery is about 0.50 D and is described to be within AE0.25, AE0.50 and AE1.00 D in 19%, 42% and 81% of the eyes, respectively (Aristodemou et al. 2011) . Thus, the refractive change following vitrectomy in pseudophakic Table 3 . Summary of measurements between the two surgeries (however not for the COMBI group), at the 1-, 3-and 12-month follow-up in the three groups compared to baseline. Notice that the COMBI group did not have a 'between' visit since their intervention was one-step. Mean AE standard deviation (percentage change compared to baseline). Number and percentage of eyes with CME in the respective groups. p-Value among the three groups. (5) 1 (5) 0 (0) 0.59 CME = cystoid macular oedema; CSMT = central subfield macular thickness; MV = macular volume. eyes is comparable to the RE in cataract surgery, but the difference is a tendency towards myopia. Various explanations have been suggested for the observed change in refraction. One explanation is the reduction of the macular thickness in eyes with ERM following vitrectomy (Sun & Choi 2011) . However, the effect of this on refraction is limited because the focal plane of the eye corresponds to the external limiting membrane and is therefore relatively unaffected by postoperative retinal thickness changes (Williams et al. 1994) . Change in effective lens position with a more posterior IOL position because of loss of the vitreous support has been suggested, but this would result in a hyperopic shift. The use of small sutureless incisions has greatly reduced the surgically induced astigmatism, and this is no longer a matter of concern in small-gauge vitrectomy (Kadonosono et al. 2006 ). We did not observe a significant surgically induced astigmatism in our study. As described in the background-section, when the vitreous gel is replaced by aqueous during vitrectomy, the difference of the index of refraction could explain (at least theoretically) a myopic shift of À0.13 and À0.50 D (Shioya et al. 1997; Sardar et al. 2007; Mehdizadeh & Nowroozzadeh 2009 ). This corresponds to the average myopic shift found in the present study, and we hypothesize that the refractive changes involved in the removal of the vitreous gel play a role in the refractive changes seen after vitrectomy. We observed insignificant myopia in some of the phakic fellow eyes, which are probably due to incipient cataract development (Pesudovs & Elliott 2003) . We used the autorefraction to guide manual refraction. The Table 5 . Summary of characteristics of the corneal endothelium in the three groups. Mean AE standard deviation. Measured at baseline, between the two surgeries (however not for the COMBI group), at the 1-, 3-and 12-month follow-up. p-Value among the three groups. autorefractor has been found to be more reproducible than manual refraction and is to be preferred when evaluating the refractive outcome (Bullimore et al. 1998 ); however, a study found that the astigmatism estimates are more accurate than spherical estimates when measured with autorefraction (Naeser & Hjortdal 2001) . It is a weakness in the retrospective nature of present study that we have no preoperative records on the ACD or the AL. Further studies of the refractive changes in pseudophakic eyes undergoing vitrectomy are needed, and they should be controlled for different variables including ACD, AL and IOL type.
Paper II
As the anatomic success of ERM surgery has improved, greater attention has been directed towards reducing the RE to maximize postoperative visual function. A small myopic shift is normally seen after vitrectomy in pseudophakic eyes, after phacovitrectomy and after cataract surgery in vitrectomized eyes . The change in refraction seems to be multifactorial and unpredictable. The sequence of surgery, especially the allocation of cataract surgery, might therefore be taken into consideration in order to improve the final refractive outcome in cases referred for ERM surgery, and this project aimed to clarify this issue.
In the present study, we found a mean myopic RE of À0.36 D for the pooled data set at the 1-month followup, À0.32 D at 3 months, stabilizing at À0.17 D 12 months after last surgical intervention. The final RE was found to be similar in both sequential and in combined surgery, and we thus found that the sequence does not play a significant role. We found a RE that is so small after 12 months that it can be considered of no clinical relevance. The power of the IOL is decided by formulas using preoperatively measured parameters. Biometric equipment is continuously improving, and refinements of the formula allow more exact prediction of postoperative refraction. Formulas are developed for cataract patients with normal retina. However, in real clinical situations, retinal diseases are common in elderly that have cataract at the same time. The ARE was within AE0.25, AE0.50 and AE1.00 D in 32%, 55% and 83% of the cases in this study after 12 months. In comparison, in cataract surgery, the ARE is within AE0.25,AE0.50 and AE1.00 D in 19%, 55-71% and 85-96%(Eleftheriadis 2003; Gale et al. 2009; Aristodemou et al. 2011; Sheard 2014) . The RE outcomes of combined surgery and cataract surgery in vitrectomized eyes are thus comparable to cataract surgery alone, and the vitreoretinal procedure seems not to have an influence on the refractive outcome in the long term (12 months). However, when starting with cataract surgery (CAT group), the proportion obtaining an ARE within 1 D is only 74%. Albeit not significant, this proportion is smaller than the two other groups (84% in the VIT-and 90% in the COMBI group).
Axial length is crucial for calculating the postoperative refraction (Olsen 1992) . The focal plane of the eye corresponds to the external limiting membrane (Williams et al. 1994) , and the IOLMaster measures the AL as the distance to the retinal pigment epithelium, making AL measurements unaffected of changes in CSMT (Olsen 2007) . In some cases of dense ERM, the optical signal is reflected from the ERM. We manually checked for double spikes, and the longest AL was approved. In cases of preoperative ocular hypertension, it has been shown that the AL decreases postoperatively, thus causing a hyperopic shift (Kim et al. 2016 ). However, none of our patients had ocular hypertension preoperatively. The discrepancy between pre-and postoperative AL measurements in our study could reflect measurement error of the equipment because of the IOL. The IOLMaster measures the AL 0.13 mm shorter in pseudophakic eyes (Rajan et al. 2002) . It might also reflect a true AL change: A few studies suggested that the myopic shift might be the result of postoperative increase in AL caused by sclera thinning or stretching in or around the sclerotomy sites after PPV (Jeoung et al. 2007 ). However, we had a decrease in AL postoperatively, which could explain the observed reduction of the myopic shift. We had no cases of use of encircling band or retinal detachment, which are factors known to influence on the AL (Huang et al. 2016) .
The position of the IOL (i.e. the effective lens plane) also plays an important role in calculating the target refraction (Olsen 2007) . The ACD is a pseudo-measurement for the effective lens plane, and the ACD increased significantly after cataract surgery (p < 0.001 in all groups), which is consistent with previous studies (Kucumen et al. 2008) . The PPV did not change the ACD neither in phakic (VIT group: p = 0.19) or pseudophakic eyes (CAT group: p = 0.98), which also is consistent with previous studies (McDermott et al. 1997; Diaz et al. 1998; Akinci et al. 2008; Byrne et al. 2008; Falkner-Radler et al. 2008) .
There is no universally accepted method of reporting CME. A determination based on angiography can be used, but an OCT-based determination is more objective, quantitative and non-invasive (Kim & Bressler 2009 ). The definition of CME on OCT also varies: some define it by a CSMT of more than an absolute value (e.g. 250 lm), or by an increment of more than 40 lm (Wittpenn et al. 2008 ), other use a percentage change (e.g. 30%) of CSMT (Singh et al. 2012) . Furthermore, CSMTs of specific OCT devices are not interchangeable due to individual segmentation algorithm, and the Heidelberg OCT measures the CSMT more than 100 lm thicker in ERM eyes compared to some other devices (Giani et al. 2010) . The lack of a uniform definition resulted in a wide range of reported incidence of CME, varying from 0 to 60% (Grzybowski et al. 2016) . Some of these definitions are further controversial and obsolete in ERM because of a preoperative high CSMT and in some cases the presence of cysts due to traction. Consequently, we defined CME as a 10% CSMT increase compared to the preoperative value (similar to the definition of the PreMEd-Study disregarding the presence of cysts; PREMED-group 2013) . This definition takes into consideration the measurement error and cases with incomplete internal limiting membrane peeling resulting in high postoperative CSMT. In order to determine whether changes in software-generated CSMT measurements are more likely to indicate real changes rather than measurement variability, it is essential to ensure the reproducibility. It was therefore necessary to review all OCT scans and CSMT measurements to ensure correct layer identification (segmentation) because of the irregular internal limiting membrane surface in ERM eyes. Reproducibility is also in part operator dependent (Bressler et al. 2014) , and we managed to minimize this source of error by having the same operator performing all the examinations. The reproducibility of CSMT measurements decreases in ERM (Lee et al. 2015) , thus making our definition of a 10% increment acceptable. A higher scan density (than what we describe in the methods) would not necessarily give additional accuracy of the CSMT and MV; it is of more importance to obtain good fixation in order to avoid motion artefacts due to fatigue. Starting with cataract surgery (CAT group) resulted in a reversible high incidence of CME (37%), an increase in CSMT and a corresponding decrease in VA. However, the number of cases with CME decreased during the follow-up period. In combined surgery, CME was noticed in a few cases 3 months after surgery, all of which resolved within the 12 months of follow-up. The two cases with persistent CME after 12 months (one in the CAT and one in the VIT group) were with no visible morphological changes (e.g. no intraretinal cysts or subretinal fluid) despite the increase of CSMT. This has also been described previously in ERM eyes in other studies (Mylonas et al. 2013) . The difference of CME incidence did not result in any difference of the RE, VA, CSMT and MV after 12 months. Thus, the CME was only a temporary issue with no impact on the functional and anatomical outcome on the long term. The CSMT continued to decrease and the VA improved at the 12-month follow-up, and other studies showed that this trend continued until 24 months (Sayegh et al. 2010) .
Our study shows that combined surgery obtains the lowest RE, the highest improvement in VA and the highest decrease in retinal thickness. It thus seems that phaco-vitrectomy is a good surgical alternative to consecutive treatment. An important finding of this study is that 17% of the patients were satisfied with cataract surgery alone (four cases in the CAT group) and had an increase of VA by seven letters on the ETDRS chart. They did not need PPV with peeling even after 12 months of follow-up. Based on these findings, we propose a treatment strategy of offering combined surgery to presbyopic patients without residual accommodation ability even if the lens is clear at the time of surgery. Although there may be several benefits of combined surgery including the economic, functional and anatomical, our recommendation is to start with cataract surgery first in cases with concomitant cataract, or if there is any doubt of whether the complaints are associated with the cataract or the ERM. The decision on whether to perform PPV can be made at the 1-month follow-up, because some of these patients might not need the PPV (17% in our study). Using this approach, the patients avoid unnecessary and possibly risky surgery, the society saves the expenses at public hospitals, and the ophthalmological clinics reduce their waiting lists for cases referred for surgery. These are important elements to consider when deciding the sequence of surgery. We believe that the status of the lens plays a key role. The same condition perhaps also applies for other surgically treated vitreomacular pathologies (i.e. macular hole and vitreomacular traction).
In summary, the principle finding of our clinical trial is that both sequential and combined surgeries induce a small RE within the tolerable range in most cases. However, 26% of the eyes in the CAT group had a RE bigger than 1 D. The monocular visual function is quite acceptable because the VA outcome is satisfying. This RE could, however, result in a not-intended anisometropia interfering with the binocular function. These ERM patients are more challenged as they might have this anisometropia in addition to an eventual residual postoperative metamorphopsia. It is therefore important to strive to minimize the RE. This study has the strength of a prospective design enabling reliable statistical analysis, and including a homogenous group of eyes with idiopathic ERM with only moderate preoperative RE (excluding high myopia, hyperopia and astigmatism). The relatively small sample size and the nonrandomized allocation are the main limitations of our study. The number of cases needed in each group was based on power calculation based on an expected RE of 0.50 D; however, our study showed a smaller RE. We found a trend towards myopia which might have been significant in a bigger sample size. Therefore, in future studies, we suggest bigger number of patients. Combined surgery obtained the most favourable outcome, but it seems reasonable to recommend starting with cataract surgery in cases with coexisting cataract in order to avoid unnecessary vitreoretinal surgery.
Paper III
In the present study, we evaluated different sequences of surgery: combined phaco-vitrectomy and two-step sequential surgery (either cataract surgery or vitrectomy first and the other procedure subsequently). We aimed to investigate the impact on the count and morphology of the EC, and on the biomechanical characteristics of the cornea. We found that all groups had a significant loss of EC after the surgical procedures, but as expected, the CED decreased only significantly after the cataract surgery, not the vitrectomy. The EC loss was slightly smaller in the group that started with cataract surgery (the CAT group) but not significantly so as compared to the other surgical strategies. One possible explanation is that these in most instances were only incipient cataracts at the time of surgery. So is the case in combined surgery (phaco-vitrectomy), which can be performed even when the lens is clear at the time of surgery, because cataract formation and progression is a common consequence of vitrectomy (Thompson 2004) . This theoretically should be an advantage for the EC, as less ultrasound energy would be required. Based on this argument one could recommend performing the cataract surgery either first or simultaneously with vitrectomy. In theory, if starting with vitrectomy and waiting for the cataract to develop, the subsequent cataract surgery will be more challenging and require more ultrasound power and energy resulting in higher EC damage (Akinci et al. 2008) . In the present study, the interval between the two steps of surgery, however, was too short (4-6 weeks) to confirm this.
We found a decrease in CED of 15-20%, which is consistent with previous studies, although the decrease ranges from 4% to 23% in different studies (Ventura et al. 2001; Mencucci et al. 2006; Storr-Paulsen et al. 2007; Hayashi et al. 2011; Reuschel et al. 2015) . In addition, the morphological indices of the EC (VAR and hexagonality) changed in all groups, but without significant difference between the groups. Due to the variability in the CED and hexagonality determined from the images (Reuschel et al. 2015) , we took the mean of three measurements (i.e. three pictures at each examination). The number of EC that need to be counted on each picture in order to obtain a maximum accuracy is controversial: some are satisfied with 30 cells (Benetz et al. 1999) , others require 75 (Doughty et al. 2000) . We aimed to have at least 75 cells at each picture analysed for improved precision. We used manual retracement, which is more accurate than the automated cell count with the IMAGE-NET software (Vecchi et al. 1996; Cheung & Cho 2000; Scarpa & Ruggeri 2016) . Controversy exists over the postoperative length of time required to evaluate the CED, but 3 months is usually accepted for cell loss and reorganization to stabilize (Bourne et al. 2004 ). In our study, the CED changed significantly between the 1 and the 3 months examinations (p = 0.022 in the COMBI group), but the CED was stable after 3 months (p > 0.21). Some have considered the CCT to be a useful indicator of EC function (Lundberg et al. 2005; Suzuki et al. 2006) . The observed transient increase in CCT with subsequent progressive decrease has previously been described in cataract surgery (Jacob 1985; Aribaba et al. 2015) , PPV (Watanabe et al. 2012) and combined surgery (Watanabe et al. 2015) . This study, in common with other studies, assessed the EC with noncontact specular microscopy in the central cornea and with a range of <1 mm 2 per picture. Thus, we did not take regional differences into account and did not evaluate the total EC function (Azen et al. 1983 ). Mapping of the corneal thickness using pachymetry software obtained with a Scheimpflug camera (in the Pentacam) can assess the entire cornea and can estimate the CV (Hayashi et al. 1994 ). The group with combined surgery had a small but statistically significant increase in CCT and CV; however, a CCT increment of 10 lm is within the range of the measurement error of repeatability of the Pentacam device (Nam et al. 2010) , and it is therefore probably a finding without clinical importance. We did not find a clear correlation between changes in CED, CV and CCT. The usefulness of the CV is still not established (Suzuki et al. 2006) , and the CED is still the widespread accepted parameter in the assessment of the surgical damage to the EC and for evaluating the invasiveness of surgery (Watanabe et al. 2015) . Following PPV for ERM, there is a small risk of retinal detachment (2%) (Rizzo et al. 2010) , which might require a second PPV with tamponade. Silicone oil tamponade is known to potentially cause keratopathy leading to EC loss and corneal decompensation (Goezinne et al. 2014 ). In our study, none of the eyes had retinal detachment or vitreous haemorrhage in the follow-up period.
The CED decreases with age (Padilla et al. 2004 ), but the decrease accelerates after cataract surgery. The annual EC loss in pseudophakic eyes is 2%, while the decrease in phakic (not operated) eyes is 1% (Cheng et al. 1985) . This makes attention to the EC even more important in younger patients. Although surgical approaches in phacoemulsification and vitreoretinal surgery are continuously improving, further refinements will additionally improve the safety for the EC (Takahashi 2016) .
In our clinical study, we could not find a statistically significant long-term difference in density or morphological characteristics of the EC following cataract surgery and PPV, either simultaneously or in various sequences. The outcomes were similar, and we found that the sequence in the present setting does not play a role. There are some limitations to this study: we did not systematically register amount of used ultrasonic energy, surgical time, pupil size and grade of cataract. We suggest considering these issues in future studies. We advocate for performing cataract surgery either first or simultaneously with vitrectomy. On the contrary, if vitrectomy is performed first which is the case in most clinics, the subsequent cataract surgery on a denser cataract will in theory cause more EC damage. As far as we know, this is the first study comparing all the three mentioned sequences in a prospective study of EC outcome.
Conclusions
A small myopic shift was found in pseudophakic eyes undergoing 23-gauge PPV for idiopathic ERM without gas tamponade. Regarding the sequence of surgery in phakic presbyopic eyes with idiopathic ERM, comparable functional (RE, BCVA) and anatomical (CME, EC loss) outcomes were found in all groups. Thus, there were no significant differences in outcomes when surgery was performed simultaneously or in various sequences. The RE was small and within the acceptable range in most cases; however, up to 26% of the eyes had a RE bigger than 1 D. This could result in anisometropia interfering with the binocular function together with a possible postoperative residual metamorphopsia. Combined phaco-vitrectomy seems to be a good surgical alternative to consecutive surgery. However, an important finding was that 17% of the eyes that started with cataract surgery did not need subsequent vitrectomy due to resolved visual complaints. This finding makes the status of the lens plays a key role. A treatment strategy of offering combined surgery to presbyopic phakic eyes with a clear lens is thus reasonable because cataract is expected to develop. In contrary, in case of a cataractous lens or doubt of whether the visual complaints are associated with the cataract or the ERM, the results of the study justify a recommendation of starting with cataract surgery. An evaluation after 1 month can decide whether to offer vitrectomy. Thereby unnecessary vitrectomy may be avoided in some of the cases (17% in this study). This strategy has several benefits: the patients avoid the risk of complications, the society saves the expenses at public hospitals, and the ophthalmological clinics reduce their waiting lists for patients referred for surgery. The main limitations of the study were the relatively small sample size and the nonrandomized allocation. Although the original intent was to randomize the participants, the randomization was not complete because some cases objected. This reflects a common challenge encountered in prospective randomized clinical trials. Nonetheless, this study provides useful guidelines to a common clinical condition (ERM) regarding the sequence of surgery, and the findings may perhaps also be applicable in other vitreoretinal diseases, for example macular hole.
Summary
Epiretinal membrane is a disease of the vitreoretinal interface that is routinely treated with PPV and internal limiting membrane peeling with excellent outcomes. In phakic eyes, the PPV accelerates the formation of cataract, and the patients therefore need a subsequent cataract surgery. The aim of this thesis was to investigate the refractive outcome, the corneal endothelial cell loss, and the incidence of CME in ERM surgery. Cystoid macular oedema was defined as a 10% increment or more in CSMT.
In Paper I, a retrospective investigation of the refractive change was made in a cohort of pseudophakic eyes undergoing 23-gauge PPV with internal limiting membrane peeling for idiopathic ERM. A significant postoperative mean change of refraction of À0.26 D (p = 0.032) and an absolute refractive change of 0.47 D were found. In Paper II and III, a comparison of three strategies of the sequence of surgery was made in a prospective interventional clinical trial. Phakic eyes with idiopathic ERM were allocated to one of three groups: (1) Cataract surgery first and PPV subsequently, (2) PPV first and cataract surgery subsequently, or (3) combined phaco-vitrectomy. The refractive prediction error (the refractive error, RE) was myopic after 3 and 12 months in all groups, and the absolute RE (ARE) ranged 0.67-0.77D after 3 months and 0.49-0.68D after 12 months. The corneal endothelial cell density (CED) decreased by 15.3-20%, and the decrease was due to cataract surgery, not PPV. There were no significant differences in final RE, ARE, visual acuity (VA) and CSMT between the groups. In the immediate postoperative period, there was a higher incidence of CME in the group that had cataract surgery first (37%), but after 12 months, there was no significant difference between the groups. Four cases (17%) in the group that started with cataract surgery had resolved visual complaints and an increase in VA after the cataract surgery, which resulted in no need for PPV within the first year of follow-up.
Surgery for idiopathic ERM in phakic eyes with either phaco-vitrectomy or sequential surgery is equal approaches with respect to functional (RE and VA) and anatomical outcomes (CME, CSMT, and CED). Based on these findings, a treatment strategy of combined surgery to presbyopic phakic eyes with a clear lens is reasonable because cataract is expected to develop. In case of a cataractous lens or doubt of whether the visual complaints are associated with the cataract or the ERM, starting with cataract surgery is rational. An evaluation after 1 month can decide whether to offer vitrectomy. Thereby vitrectomy may be avoided in some of the cases (17% in this study).
